INS and hyperlipidemia: In vivo, mice treatment with palmitate phosphorylates DDX1 and displaces it from the pre-proinsulin mRNA, suppressing insulin biosynthesis and indicating a direct link between hyperlipidemia and insulin deficiency [109].